Medical centers across the U.S. are investing in genomic sequencing in the race to bring precision medicine to the clinic. Phoenix Children's Hospital, Harvard Medical School, Weill Cornell Medical College, Memorial Sloan-Kettering Cancer Center and Johns Hopkins are among the institutions that see a future in analyzing patients' genomic data to find better cancer therapies. By investing in infrastructure, the medical centers could help discover breakthrough drugs that cure patients and return financial rewards.

Related Summaries